So it is possible that Pharma due dilligence is linked to the Euro trials...
See the announcement "Update on EU Clinical Trial and Commercial Negotiations" on the 20/12/2010 which states two key points: 1. Data for commercial negotiations with global wound care companies has come from the "Canadian & Australian Clinical Trial" (p3) 2. Commercial partner deal not dependent on EU trial results (p4)
Grum11: Good to hear, I hope you get something out of it :)
TIS Price at posting:
66.6¢ Sentiment: Buy Disclosure: Held